William A. Haseltine, Contributor

Author's posts

Even Mild Covid-19 May Cause Lasting Brain Fog (Part 2)

For many people, an encounter with Covid-19 brings with it lingering cognitive
symptoms, a new study describes why and how this might be happening.

Even Mild Covid-19 May Cause Lasting Brain Fog (Part 1)

Even mild Covid-19 may worsen cognitive health. How? By triggering a strong inflammatory response that makes its way to the central nervous system, leading to overabundant activation of immune cells in the brain.

Progress In The Search For Broadly Neutralizing Monoclonal Antibodies V

Two more antibodies, COV44-62 and COV44-79, broadly neutralize a wide range of SARS-CoV-2 variants.

Covid-19, Gender And Immune Response: What’s The Relationship?

This is the first installment in a two part series which analyzes biological sex differences in immune responses to SARS-CoV-2 infection. This article focuses on Covid-19 related viral entry as well as innate and adaptive immune responses Covid-19 and …

A Cooling, Implantable Device For Pain Relief

Scientists at Northwestern University have engineered a new pain-relieving device that could serve as a replacement for opioids or other highly addictive medications.

Progress In The Search For Broadly Neutralizing Monoclonal Antibodies IV

The ZCB11 antibody demonstrates strong neutralization of all major variants, adding itself to the growing list of broadly neutralizing monoclonal treatments.

Progress In The Search For Broadly Neutralizing Monoclonal Antibodies III

A new antibody, SP1-77, displays strong neutralization of all SARS-CoV-2 variants, including Omicron BA.4/5.

New-Wave Materials Help Create Mini Functional Kidneys

We may be one step closer to developing artificial kidneys as a replacement for kidney donor transplants.

Can Inflammation Lead To Cognitive Issues? Past Research Says ‘Yes’, With Implications For Covid-19

Reports of cognitive issues following a bout of Covid-19 are now quite common. In some cases, these symptoms may persist for months or years as part of Long Covid. Prior research on cancer and aging may provide a valuable starting point on the journey …

New SARS-CoV-2 Variant BA.2.75 Evades All Approved Monoclonal Antibody Therapies

The latest in the Omicron family of variants, BA.2.75, is more resistant to monoclonal antibodies than its predecessors, posing problems for treating Covid-19.